Burke Steven Keith

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$119,220.00
Insider Sells Quantity
15
Insider Sells Sum
$366,758.83

Insider Activity of Burke Steven Keith

According to the SEC Form 4 filings, Burke Steven Keith, being in a position of

  1. SVP, Chief Medical Officer at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 57650 shares for $119,136,
    over all time since 2019-11-20, has bought 27000 shares for $96,660, and sold 235610 shares for $366,759.

The largest purchase of all time was on 2019-11-20 and amounted to 27000 shares of Akebia Therapeutics, Inc. for $96,660.

The largest sale of all time was on 2025-02-03 and amounted to 50506 shares of Akebia Therapeutics, Inc. for $106,063.

Biography of Burke Steven Keith

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $119,1362100

Comparison of Insiders on Amount of Buys and Sells

2025-03-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,144
0.0033%
$1.83$13,074+5.56%
2025-02-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
50,506
0.0217%
$2.10$106,063-9.2%
2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,169
0.0038%
$1.58$11,327-7.28%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
8,367
0.0041%
$1.52$12,718-10.37%
2024-02-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
24,311
0.0133%
$1.68$40,842-15.5%
2023-08-25SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
27,000
0.0145%
$1.15$31,050+9.57%
2023-05-16SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
63,567
0.035%
$1.07$67,890+20%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
14,123
0.0074%
$0.88$12,393+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,539
0.0041%
$0.81$6,131+38.48%
2022-08-31SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,147
0.0006%
$0.36$416+92.31%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,656
0.0043%
$2.17$16,619-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,400
0.0041%
$2.15$15,946-81.02%
2021-08-31SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,042
0.0006%
$2.83$2,949-32.14%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
1,081
0.0007%
$3.40$3,675-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
7,558
0.005%
$3.40$25,668-14.84%
2019-11-20PurchaseAkebia Therapeutics, Inc.
AKBA
SVP, Chief Medical Officer
27,000
0.0244%
$3.58$96,660+130.84%
2017-12-15PurchaseProtara Therapeutics, Inc.
TARA
SVP and Chief Medical Officer
12,000
0.0693%
$1.88$22,560+18.92%
Total: 17
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.